Drug Shortage Report for QUETIAPINE FUMARATE XR
Report ID | 223365 |
Drug Identification Number | 02516640 |
Brand name | QUETIAPINE FUMARATE XR |
Common or Proper name | QUETIAPINE FUMARATE XR |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-09-30 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-03-26 | French | Compare |
v1 | 2024-03-26 | English | Compare |
Showing 1 to 2 of 2